Abstract 21P
Background
The malignant progression of bladder cancer is a key influencing factor for its poor prognosis. In recent years, numerous studies have shown that circular RNA (circRNA) can regulate the expression of genes in multi-levels, which may play a key role in malignant tumors.
Methods
This study applied bioinformatics methods to preliminarily screened the differentially expressed circular RNAs between bladder cancer and corresponding adjacent tissue. Real-time quantitative PCR(RT-qPCR) experiments were performed to identify differentially expressed circular RNAs in cell lines and tissues of bladder cancer. The functional experiments including plate cloning, CCK-8, Edu and xenograft tumor models were implemented to investigate the biological behavior changes of bladder cancer induced by knocking down hsa_circ_0009061 in vitro and in vivo. Bioinformatics methods were applied to predict miRNAs that circular RNA might bind to and the miRNA target genes, and the real-time quantitative PCR, RNA pulldown,dual luciferase reporter experiment and western blot were utilized to explore the mechanism of hsa_circ_0009061 regulating bladder cancer progression.
Results
The bioinformatics analysis and RT-qPCR find that hsa_circ_0009061 was downregulated in cell lines and tissues of bladder cancer. After successfully knocking down hsa_circ_0009061 in bladder tumor cells, functional experiments including plate cloning, Edu and CCK-8 revealed that silencing hsa_circ_0009061 could promote the malignant proliferation of bladder tumor cell lines in vitro. Xenograft tumor modelalso verified that silencing hsa_circ_0009061 could promote tumor formation in vivo. Mechanistic studies have shown that hsa_circ_0009061 can act as a competitive endogenous RNA to bind to hsa-miR-889-3p and regulate the expression of CPEB3, resulting in the malignant progression of bladder cancer.
Conclusions
This study found that hsa_circ_0009061 was downregulated in cell lines and tumor specimens of bladder cancer and could affect the progression of bladder cancer. Mechanistically, hsa_circ_0009061 can bind to hsa-miR-889-3p to regulate the expression of CPEB3, suggesting that hsa_circ_0009061 may be a new treatment option for bladder cancer.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
10P - An adapted CGP-based model to interpret POLE mutations in endometrial cancer
Presenter: Rita Trozzi
Session: Cocktail & Poster Display session
Resources:
Abstract
11P - Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations
Presenter: Rija Zaidi
Session: Cocktail & Poster Display session
Resources:
Abstract
12P - Swiss-PO: Molecular modelling for precision oncology
Presenter: Fanny Krebs
Session: Cocktail & Poster Display session
Resources:
Abstract
13P - A novel algorithm for predicting variant detectability in oncogenomic analysis
Presenter: Alper Akkuş
Session: Cocktail & Poster Display session
Resources:
Abstract
14P - expHRD: An algorithm for the transcriptome-based estimation of homologous recombination deficiency score
Presenter: Jin-Ku Lee
Session: Cocktail & Poster Display session
Resources:
Abstract
15P - ClinBioNGS: An integrated clinical bioinformatics pipeline for the analysis of somatic NGS cancer panels
Presenter: Xavier Sole
Session: Cocktail & Poster Display session
Resources:
Abstract
16P - Investigation of c-MYC role in DNA-PK-mediated activation of STING pathway in SCLC
Presenter: Caterina de Rosa
Session: Cocktail & Poster Display session
Resources:
Abstract
17P - NRF2 activation promotes HER2-targeted tolerance and resistance in oesophageal adenocarcinoma through metabolic reprogramming to glutathione
Presenter: Wei Zhang
Session: Cocktail & Poster Display session
Resources:
Abstract
18P - AURKB inhibition radiosensitises NSCLC by altering mitotic fate
Presenter: Kathryn Egerton
Session: Cocktail & Poster Display session
Resources:
Abstract
19P - Stratified control study on neuroendocrine differentiation and potential clinical markers in patients with limited-stage small-cell lung cancer
Presenter: Li Liu
Session: Cocktail & Poster Display session
Resources:
Abstract